Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Thrasos Therapeutics Inc.
DescriptionSmall peptide targeting the bone morphogenetic protein (BMP) signaling pathway
Molecular Target Bone morphogenetic protein receptors
Mechanism of ActionBone morphogenetic proteins agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Renal (unspecified)
Indication DetailsSlows progression of chronic kidney disease (CKD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today